Bárbara Heather Lutz, Iná da Silva Dos Santos, Marlos Rodrigues Domingues, Joseph Murray, Mariângela Freitas da Silveira, Vanessa Irribarem Avena Miranda, Marysabel Pinto Telis Silveira, Sotero Serrate Mengue, Tatiane da Silva Dal Pizzol, Andréa Dâmaso Bertoldi
{"title":"孕期补充叶酸和产后抑郁症状。","authors":"Bárbara Heather Lutz, Iná da Silva Dos Santos, Marlos Rodrigues Domingues, Joseph Murray, Mariângela Freitas da Silveira, Vanessa Irribarem Avena Miranda, Marysabel Pinto Telis Silveira, Sotero Serrate Mengue, Tatiane da Silva Dal Pizzol, Andréa Dâmaso Bertoldi","doi":"10.11606/s1518-8787.2023057004962","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To verify whether folic acid supplementation during pregnancy is associated with the occurrence of maternal depressive symptoms at three months postpartum, in the 2015 Pelotas Birth Cohort.</p><p><strong>Methods: </strong>This study included 4,046 women, who were classified into three groups: did not use folic acid supplementation during pregnancy; used during only one trimester of pregnancy; and used for two or three trimesters. Depressive symptoms were assessed at three months postpartum using the Edinburgh Postnatal Depression Scale (EPDS), at cutoff points ≥ 10 (mild symptoms) and ≥ 13 (moderate to severe intensity).</p><p><strong>Results: </strong>The overall prevalence of mild symptoms was of 20.2% (95%CI 19.0-21.5), and moderate and severe was 11% (95%CI 10.0-12.0). The prevalence of EPDS ≥ 10 was of 26.8% (95%CI 24.0-29.5) among women who did not use folic acid and 18.1% for both those who used it during one trimester of pregnancy (95%CI 16.1-20.1) and those who used it for two or three trimesters (95%CI 16.0-20.2). The prevalence of EPDS ≥ 13 was of 15.7% (95%CI 13.5-17.9) in those who did not use folic acid, 9.1% (95%CI 7.5-10.6) in those who used it for one trimester, and 9.4% (95%CI 7.8-11.0) in those who used it for two or three trimesters. In the adjusted analyses, there was no statistically significant association between the use of folic acid during pregnancy and the occurrence of depressive symptoms at three months postpartum.</p><p><strong>Conclusion: </strong>There was no association between folic acid supplementation during pregnancy and postpartum depression at three months.</p>","PeriodicalId":21230,"journal":{"name":"Revista de saude publica","volume":"57 ","pages":"76"},"PeriodicalIF":2.1000,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609648/pdf/","citationCount":"0","resultStr":"{\"title\":\"Folic acid supplementation during pregnancy and postpartum depressive symptoms.\",\"authors\":\"Bárbara Heather Lutz, Iná da Silva Dos Santos, Marlos Rodrigues Domingues, Joseph Murray, Mariângela Freitas da Silveira, Vanessa Irribarem Avena Miranda, Marysabel Pinto Telis Silveira, Sotero Serrate Mengue, Tatiane da Silva Dal Pizzol, Andréa Dâmaso Bertoldi\",\"doi\":\"10.11606/s1518-8787.2023057004962\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To verify whether folic acid supplementation during pregnancy is associated with the occurrence of maternal depressive symptoms at three months postpartum, in the 2015 Pelotas Birth Cohort.</p><p><strong>Methods: </strong>This study included 4,046 women, who were classified into three groups: did not use folic acid supplementation during pregnancy; used during only one trimester of pregnancy; and used for two or three trimesters. Depressive symptoms were assessed at three months postpartum using the Edinburgh Postnatal Depression Scale (EPDS), at cutoff points ≥ 10 (mild symptoms) and ≥ 13 (moderate to severe intensity).</p><p><strong>Results: </strong>The overall prevalence of mild symptoms was of 20.2% (95%CI 19.0-21.5), and moderate and severe was 11% (95%CI 10.0-12.0). The prevalence of EPDS ≥ 10 was of 26.8% (95%CI 24.0-29.5) among women who did not use folic acid and 18.1% for both those who used it during one trimester of pregnancy (95%CI 16.1-20.1) and those who used it for two or three trimesters (95%CI 16.0-20.2). The prevalence of EPDS ≥ 13 was of 15.7% (95%CI 13.5-17.9) in those who did not use folic acid, 9.1% (95%CI 7.5-10.6) in those who used it for one trimester, and 9.4% (95%CI 7.8-11.0) in those who used it for two or three trimesters. In the adjusted analyses, there was no statistically significant association between the use of folic acid during pregnancy and the occurrence of depressive symptoms at three months postpartum.</p><p><strong>Conclusion: </strong>There was no association between folic acid supplementation during pregnancy and postpartum depression at three months.</p>\",\"PeriodicalId\":21230,\"journal\":{\"name\":\"Revista de saude publica\",\"volume\":\"57 \",\"pages\":\"76\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-11-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609648/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de saude publica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.11606/s1518-8787.2023057004962\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de saude publica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.11606/s1518-8787.2023057004962","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Folic acid supplementation during pregnancy and postpartum depressive symptoms.
Objective: To verify whether folic acid supplementation during pregnancy is associated with the occurrence of maternal depressive symptoms at three months postpartum, in the 2015 Pelotas Birth Cohort.
Methods: This study included 4,046 women, who were classified into three groups: did not use folic acid supplementation during pregnancy; used during only one trimester of pregnancy; and used for two or three trimesters. Depressive symptoms were assessed at three months postpartum using the Edinburgh Postnatal Depression Scale (EPDS), at cutoff points ≥ 10 (mild symptoms) and ≥ 13 (moderate to severe intensity).
Results: The overall prevalence of mild symptoms was of 20.2% (95%CI 19.0-21.5), and moderate and severe was 11% (95%CI 10.0-12.0). The prevalence of EPDS ≥ 10 was of 26.8% (95%CI 24.0-29.5) among women who did not use folic acid and 18.1% for both those who used it during one trimester of pregnancy (95%CI 16.1-20.1) and those who used it for two or three trimesters (95%CI 16.0-20.2). The prevalence of EPDS ≥ 13 was of 15.7% (95%CI 13.5-17.9) in those who did not use folic acid, 9.1% (95%CI 7.5-10.6) in those who used it for one trimester, and 9.4% (95%CI 7.8-11.0) in those who used it for two or three trimesters. In the adjusted analyses, there was no statistically significant association between the use of folic acid during pregnancy and the occurrence of depressive symptoms at three months postpartum.
Conclusion: There was no association between folic acid supplementation during pregnancy and postpartum depression at three months.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
